To compare the effects of antiemetics on the prevention of acute, delayed and overall chemotherapy-induced nausea and vomiting in adults with solid cancer or haematological malignancies receiving moderately or highly emetogenic chemotherapy and to generate a clinically meaningful treatment ranking according to their safety and efficacy.